Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1537, 2006-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral, not transdermal, estrogens raise thromboembolism risk
Reactions Weekly, Vol. 1, Iss. 1291, 2010-01 ,pp. :
Oral HRT doubles venous thromboembolism risk
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Hormonal contraceptive use appears to reduce bacterial vaginosis risk
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
Bevacizumab: increased risk of venous thromboembolism
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :
Bevacizumab: increased risk of venous thromboembolism
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :